Lip cancer treatment with high dose rate brachytherapy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 14597364.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We present 39 patients with lip carcinoma treated with HDR, (needles) with 5-5.5 Gy per 8-10 fractions b.i.d. (total dose 40.5-45 Gy). Three-year cause-specific survival and local control are 91 and 88% (95% T1-2, 74% T4, p<0.05). Acute and chronic reactions are like LDR cases. We think that HDR results are equivalent to LDR.
Medical subject headings
- Brachytherapy
- Carcinoma, Squamous Cell
- Lip Neoplasms